- Nigeria's coronavirus cases are now officially 48,116 after confirmation of 373 new cases
- This was announced by the Nigeria Centre for Disease Control (NCDC) on Thursday, August 13
- In the latest data released by the NCDC, Borno and Bauchi have one case each recorded in their states
PAY ATTENTION: Click “See First” under the “Following” tab to see Legit.ng News on your Facebook News Feed!
The Nigeria Centre for Disease Control (NCDC) on Thursday, August 13 reported that there are 373 new cases of coronavirus in Nigeria.
The NCDC via its official Twitter account revealed that the new cases are as follows:
This means there are now 48,116 confirmed cases of COVID-19 reported in Nigeria.
While 34,309 have been discharged, 966 people have died due to the viral disease.
The federal government, on Wednesday, August 12 said Nigeria had not placed an order for any vaccines from Russia.
The government made the clarification following reports that about 20 countries had ordered billions of the Russian vaccine. Russian President Vladimir Putin announced the approval of the coronavirus vaccine, Sputnik V, for use on Tuesday, August 11.
The executive director of the National Primary Health Care Development Agency (NPHCDA), Dr Faisal Shuaib, said: “Nigeria has not ordered any vaccines from Russia. Nigeria is working with many critical stakeholders to access vaccines that have gone through the required clinical trials and approval processes.
“So in the end, whatever vaccines come to Nigeria, they would be of globally-acceptable standards.”
Recall that the three phases of human trials by Russia have successfully been completed as the country plans to go into mass production.
The country has two test candidates. One is for a vaccine being worked on by the Vektor State Research Centre of Virology and Biotechnology while the second is being handled by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology in collaboration with the Russian Defence Ministry.
Meanwhile, Legit.ng earlier reported that scientists inched closer to developing a vaccine for the coronavirus following a report which stated that a COVID-19 experimental vaccine developed by Moderna Inc was safe and provoked immune responses from all patients tested in an initial safety trial.
In the test conducted on Tuesday, July 14, patients who volunteered were given two doses of the vaccine.
The team which carried out the trials reported that patients showed high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19.
Lagos school prepares isolation centre for Covid-19 emergency | Legit TV